Regulatory effect of Traditional Chinese Medicinal Formula Zuo-Gui-Wan on the Th17/Treg paradigm in mice with bone loss induced by estrogen deficiency

被引：34

作者：

Lai, Nannan ^{[1
,2
,3
,4
]}

Zhang, Zhirong ^{[5
]}

Wang, Bin ^{[6
]}

Miao, Xiuming ^{[6
]}

Guo, Yuqi ^{[1
,2
,3
,4
]}

Yao, Chengfang ^{[1
,2
,3
,4
]}

Wang, Zhaoxia ^{[1
,2
,3
,4
]}

Wang, Li ^{[1
,2
,3
,4
]}

Ma, Ruiping ^{[7
]}

Li, Xia ^{[1
,2
,3
]}

Jiang, Guosheng ^{[1
,2
,3
]}

机构：

[1] Shandong Acad Med Sci, Inst Basic Med, Key Lab Tumor Immunol & Tradit Chinese Med Immuno, Jinan 250062, Peoples R China

[2] Shandong Acad Med Sci, Inst Basic Med, Key Lab Rare & Uncommon Dis, Jinan 250062, Peoples R China

[3] Shandong Acad Med Sci, Inst Basic Med, Minist Publ Hlth, Key Lab Biotechnol Drugs, Jinan 250062, Peoples R China

[4] Shandong Acad Med Sci, Inst Basic Med, Lab Immunopharmacol State Adm Tradit Chinese Med, Jinan 250062, Peoples R China

[5] Shandong Univ, Yantai Yuhuangding Hosp, Dept Reprod Ctr, Jinan 250012, Peoples R China

[6] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan 250011, Peoples R China

[7] Qianfo Hosp Shandong Prov, Jinan 250014, Peoples R China

来源：

JOURNAL OF ETHNOPHARMACOLOGY | 2015年 / 166卷

关键词：

Zuo-Gui-Wan; Bone loss; Estrogen deficiency; Th17/Treg paradigm; Transcription factor; Cytokine; T-CELLS; IMMUNE-SYSTEM; TH17; CELLS; OSTEOIMMUNOLOGY; WOMEN; HEALTH; TREG;

D O I：

10.1016/j.jep.2015.03.011

中图分类号：

Q94 [植物学];

学科分类号：

071001 ;

摘要：

Ethnopharmacological relevance: Bone loss is a common pathological condition induced by estrogen deficiency. The Th17/Treg paradigm, which can be skewed by estrogen, plays an important role in regulating bone metabolism Aim of the study: The purpose of this study was to determine the role of the Th17/Treg shift in estrogen deficiency-induced bone loss in mouse models and to elucidate the immunopharmacologic mechanism of Zuo-Gui-Wan (ZGW) in preventing bone loss in this process by regulating Th17/Treg paradigm. Materials and methods: Splenocytes of ovariectomized (Ovx) mice and naturally aged mice were isolated and Flow cytometry was used to detect the Th17/Treg subsets. In addition, serum estrodiol (E-2) and serum C-terminal telopeptides of type I collagen (CTx) were detected by ELISA assay. Bone mineral density (BMD) of the left tibiae was measured by dual-energy X-ray absorptiometry. Moreover, Ovx mice were administrated with different doses of ZGW for 12 weeks, and BMD and Th17/Treg subsets were determined. Bone histomorphometry was observed by Hematoxylin and eosin (H&E) staining and serum protein levels of IL-6 were analyzed by ELISA assay. In addition, the mRNA and protein expression of ROR gamma t and Foxp3 were detected by RT-PCR and Western blot respectively. Result: The Th17/Treg paradigm shifted to Th17 in estrogen-deficient mice both in the Ovx mice and the naturally aged mice. BMD and E-2 levels negatively correlated with the Th17/Treg ratio. After ZGW administration, the BMD was enhanced markedly in the Ovx mice as well as in the naturally aged mice. Both the mRNA and protein expressions of IL-6 and ROR gamma t were decreased, whereas those of Foxp3 were increased significantly after ZGW administration. Conclusion: Th17/Treg shift involved in the bone loss induced by estrogen deficiency. ZGW prevented bone loss efficiently and skewed Th17/Treg paradigm towards Treg without enhancing E-2. (c) 2015 Elsevier Ireland Ltd. All rights reserved.

引用

页码：228 / 239

页数：12

共 69 条

[21]

Gong Q.F., 2008, CHINA J CHIN MAT MED, V33, P1272

[22] Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].

Harrington, LE ;

Hatton, RD ;

Mangan, PR ;

Turner, H ;

Murphy, TL ;

Murphy, KM ;

Weaver, CT .

NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132

[23] Postmenopausal women with hormone receptor-positive breast cancer: Balancing benefit and toxicity from aromatase inhibitors [J].

Ingle, James N. .

BREAST, 2013, 22 :S180-S183

[24] The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells [J].

Ivanov, Ivaylo I. ;

McKenzie, Brent S. ;

Zhou, Liang ;

Tadokoro, Carlos E. ;

Lepelley, Alice ;

Lafaille, Juan J. ;

Cua, Daniel J. ;

Littman, Dan R. .

CELL, 2006, 126 (06) :1121-1133

[25] Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis [J].

Kelchtermans, H. ;

Geboes, L. ;

Mitera, T. ;

Huskens, D. ;

Leclercq, G. ;

Matthys, P. .

ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) :744-750

[26] Interleukin-17: A new paradigm in inflammation, autoimmunity, and therapy [J].

Kramer, Jill M. ;

Gaffen, Sarah L. .

JOURNAL OF PERIODONTOLOGY, 2007, 78 (06) :1083-1093

[27] Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study [J].

Le Ray, Isabelle ;

Dell'Aniello, Sophie ;

Bonnetain, Franck ;

Azoulay, Laurent ;

Suissa, Samy .

BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) :603-609

[28] Developmental plasticity of Th17 and Treg cells [J].

Lee, Yun Kyung ;

Mukasa, Ryuta ;

Hatton, Robin D. ;

Weaver, Casey T. .

CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (03) :274-280

[29] Estrogen Receptor α Signaling in T Lymphocytes Is Required for Estradiol-Mediated Inhibition of Th1 and Th17 Cell Differentiation and Protection against Experimental Autoimmune Encephalomyelitis [J].

Lelu, Karine ;

Laffont, Sophie ;

Delpy, Laurent ;

Paulet, Pierre-Emmanuel ;

Perinat, Therese ;

Tschanz, Stefan A. ;

Pelletier, Lucette ;

Engelhardt, Britta ;

Guery, Jean-Charles .

JOURNAL OF IMMUNOLOGY, 2011, 187 (05) :2386-2393

[30]

Li Bing-Yan, 2006, Shengli Xuebao, V58, P573

← 1 2 3 4 5 6 7 →